Medicine

Jing Guo, Teng Li, Liang Liang, Jialiang Huang, Youqiong Li

2026.5.1HEMOGLOBIN

DOI: 10.1080/03630269.2026.2664191

Abstract

We describe a pregnant woman with a genotype consistent with β-thalassemia major but a phenotype suggestive of the β-thalassemia trait. Routine genetic testing revealed a homozygous CD41/42(-TTCT) (HBB:c.126_129delCTTT) mutation in the β-globin gene. Hemoglobin electrophoresis showed an Hb F level of 98.9% and an Hb A2 level of 1.1%, while the complete blood count indicated an Hb concentration of 98 g/L. Pedigree analysis confirmed that both parents were heterozygous CD41/42(-TTCT) carriers, consistent with their mild clinical presentations. Further investigations using multiplex ligation-dependent probe amplification excluded copy number variations in the α- and β-globin gene clusters, and third-generation sequencing ruled out potential cis-acting mutations. Sanger sequencing confirmed that the proband harbored two mutations in the γ-globin chain (Gγ-158 C > T and Aγ + 25 G > A). Because her husband was also a heterozygous carrier of the same mutation, prenatal diagnosis was performed and indicated a homozygous CD41/42(-TTCT) genotype in the fetus. This marked genotype-phenotype discordance in the pregnant woman posed a significant challenge for prenatal genetic counseling. Ultimately, given the current limitations in understanding such phenotypic variations, the couple decided to terminate the pregnancy.

Citation format

GUO, Jing, et al. Prenatal counseling conundrum: Unexpectedly mild phenotype in a pregnant woman with homozygous CD41/42(-TTCT) β-thalassemia. HEMOGLOBIN, 2026, 50 3(3): 282–287.